about
The swine flu pandemic--should we be concerned?A classification system for mortality and morbidity abstracts and related data.Use of cost data, provider experience, and clinical guidelines in the transition to managed care.Managed care: electronic data interchange.Life table reconstruction from annual data for survival rate, P, and entrants, l.Mortality from cerebrovascular disease. A study based on data from hospitalization benefits.Cystic fibrosis mortality: registry data of cystic fibrosis.Browsing Mendel's library: appreciating the enormous heterogeneity of human genomes.Screening potential elderly preferred markers: exploratory analysis of Cardiovascular Health Study (CHS) data.Mortality and prescription drug use: an analysis using the CHS limited access data.Converting Lab Report Files into Usable Data.Minor traumatic brain injury: review of clinical data and appropriate evaluation and treatment.Prognosis of hypertrophic cardiomyopathy.Mortality outcomes of various causes of syncope.The Long QT Syndrome: A Review and Mortality Analysis.Coronary heart disease in the elderly--underwriting and pricing issues.Newer cardiac imaging techniques: multidetector CT angiography.AIDS analysis: experience from Savings Bank Life Insurance Company.Tumor markers: issues from an insurance perspective.Reintroduction to classical genetics.Molecular biology and the "new genetics.".The genetics of coronary artery disease.Two not-quite-Jurassic classics, and some mathematica prostatica.AIDS-related insurance claim experience.Statistical analysis of HIV seropositive results from 1988-1993 performed on life insurance applicants.Mycosis fungoides--an underwriting prospective with emphasis on staging and risk selection.Workers Compensation cases with traumatic brain injury: an insurance carrier's analysis of care, costs, and outcomes.Managed care: technology assessment and technology control.Quantitative EEG analysis and rehabilitation issues in mild traumatic brain injury.Cognitive disability and reimbursement for rehabilitation and psychiatry.Hemochromatosis 1991. What will increased clinical screening mean for medical directors?T-wave abnormalities in bundle branch block.Centers of excellence: choosing the appropriate rehabilitation center.Medical consultation and expert testimony in claims litigation. Professional and ethical guidelines.Managed care: practice parameters.Managed care: the strategic future for education in quality.Managed care: provider profiling.Activities of daily living: tools to measure functional loss.Alternative psychological methods in patient care. Council on Scientific Affairs, American Medical Association.Physicians in insurance management. An expanding opportunity for physician executives.
P1433
Q30387875-6E05D02F-C060-418F-BE21-647A82AB83CBQ30569604-EED965B2-3961-485E-987B-34F570DDFCB2Q30569608-6E2119F7-FB0E-4CFB-886B-C5035C45E98DQ30569669-FFF90874-7C3D-4474-AA46-3A0CA7CFCEC2Q30569672-6DBFFE39-37B6-49D6-909F-8FF8263E76F3Q30570327-5A98087F-D53C-4947-A5A7-04E6ACEE2564Q30572192-F742C8AA-7DF6-4C90-BB59-13E33B02E7E5Q30664917-357646F7-9DD1-47D3-A377-A6FAACCC31F3Q30971190-FCDB713B-02E8-4C85-B8F2-8E94000236E8Q31112508-DBD51B65-EA0C-4EC2-8D05-7752134B01A7Q31126092-292CE2E0-D0C6-4BB6-94B4-38CFB5154BD4Q31270346-4EFB29B3-B621-439D-9B6C-802175389EB6Q33144624-BA7C04D0-A883-4EF6-9F8B-EFA330884C48Q33151313-D9806AB9-986C-44FF-99D7-508D2070A600Q33167647-75E2D397-3369-4709-BE00-8AD3D1504158Q33215144-E1D116FC-536A-4CBD-BB40-D9756BE687BDQ33250390-591E7177-7431-40E3-97B4-E19ECAAAC81AQ33443393-F3D641E6-5AA6-4CB9-A824-AE2277AEDA04Q33559430-D0839412-6431-49CB-8A64-1BA6223C9B65Q33559494-9D6C0C6E-9F88-4DB0-AD85-4668BB2B84B5Q33559499-35DBF593-A25E-4FA5-8C9F-961B16DD3412Q33559504-0A7501D7-D179-4EB7-B706-C98E019784BFQ33559606-4ABCE7E2-5701-4D1C-9128-9F44CDA98513Q33560445-FAAFB0DF-E58E-4969-8EC1-A662B231F0DDQ33560450-BFD98B97-B871-4C8A-8BE4-D895BB71532AQ33560477-C08700BC-DC7A-4408-B95B-4C64F2C17327Q33561348-F6D75DAA-5641-4C92-BA2D-A5C93D98DEADQ33561453-ACB52401-2D66-419E-9837-A2E363ABB9A8Q33561459-853948A0-E4B4-44D5-87FA-155D026097C8Q33561465-4F44C969-3712-4198-AFB0-689447084C83Q33561469-F5E0999B-C6C8-4DD0-BA56-416687C6825FQ33562808-3D258614-2062-4FBE-A264-DF9459938CD3Q33562838-9681CA11-029A-4052-9105-B915C23917D8Q33562842-B4C30B0D-36EB-4952-BE87-EB6B9FFCACCEQ33562847-C136E779-24F6-4BF0-8BD8-07CF44EF0E1BQ33562854-56068DFD-7C01-4494-BB63-956406C8C267Q33562860-8B969A4A-AD00-4105-A287-094F89678223Q33562866-0F8F308E-62C0-4BD5-BF08-B41D02F7AD36Q33562873-4DFA79FA-CDDD-4B6F-BF73-B1FF4BA6EEC3Q33562877-041614AD-8069-47B8-976C-121718899330
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of insurance medicine (New York, N.Y.)
@ast
Journal of insurance medicine (New York, N.Y.)
@en
Journal of insurance medicine (New York, N.Y.)
@es
Journal of insurance medicine (New York, N.Y.)
@it
Journal of insurance medicine (New York, N.Y.)
@nl
type
label
Journal of insurance medicine (New York, N.Y.)
@ast
Journal of insurance medicine (New York, N.Y.)
@en
Journal of insurance medicine (New York, N.Y.)
@es
Journal of insurance medicine (New York, N.Y.)
@it
Journal of insurance medicine (New York, N.Y.)
@nl
altLabel
J Insur Med
@en
prefLabel
Journal of insurance medicine (New York, N.Y.)
@ast
Journal of insurance medicine (New York, N.Y.)
@en
Journal of insurance medicine (New York, N.Y.)
@es
Journal of insurance medicine (New York, N.Y.)
@it
Journal of insurance medicine (New York, N.Y.)
@nl
P1055
P1156
P1476
Journal of insurance medicine (New York, N.Y.)
@en